Answers are grounded in this paper and cite their sources.
A highly effective, atom-economical, and environmentally friendly strategy to CO2 utilisation is the solvent-free direct production of styrene carbonate (SC) from styrene oxide (SO) and CO2. This work describes a substantially effective catalytic system utilizing Fe-graphitic carbon nitride (Fe-GCN) for the selective production of SC. Fe-GCN with a small loading of around 1.68 wt.% Fe functions as an efficient heterogeneous catalyst for the CO2 cycloaddition with SO, in contrast to many conventional catalysts. It operates more effectively than other Fe-supported catalysts, with its increased activity ascribed to the synergistic interaction between Fe and N sites. A comprehensive analysis of surface functionalities and structural characteristics, including detailed XPS, kinetics, and reaction data, revealed that optimised Fe-GCN achieves an enhanced SC yield of 86% with over 99% selectivity under mild conditions (353 K, 0.2 MPa CO2) within 3 h. XPS analysis, NH3 TPD profiles, control experiments, and DFT studies confirmed the importance of pyridinic-N and Fe3+ in catalysis. Essentially, pyridinic basic sites activate CO2 to interact with SO, a process facilitated by vicinal, strongly acidic Fe3+ sites. The co-activated CO2 and SO then react to form SC. The design of Fe-GCN as a catalyst played a significant role in improving activity, with the cooperative behavior of active sites also contributing to improved conversion of both internal and terminal epoxides from different substrates.
No takes yet. Share an insight, caveat, or question.
Khairun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: